Laudanum are generally confined to controlling diarrhea, alleviating pain, and easing withdrawal symptoms in infants born to mothers addicted to heroin or other opioids. Recent enforcement action by the U.S. Food and Drug Administration (FDA) against manufacturers of paregoric and opium tincture suggests that opium tincture's availability in the U.S. may be in jeopardy. The terms "laudanum" and "tincture of opium" are generally interchangeable, but in contemporary medical practice the latter is used almost exclusively. Paracelsus, a 16th-century Swiss-German alchemist, experimented with various opium concoctions, and recommended opium for reducing pain. One of his preparations, a pill which he extolled as
Pennsylvania Department of Drug and Alcohol Programs has been proven successful to those trying to remedy their addictions. DDAP provides access to programs such as the prescription drug take back program, overdose awareness, and information on rehab centers. One of their main projects, is to spread the knowledge and availability of Naloxone, which is a medication that can reverse an overdose caused by an Opioid drug overdose. They have made progress on this front by enacting ACT 139, which gives first responders, friends, and families access to the opioid overdose reversal medicine, this way more lives can be saved by a quicker treatment response. Within the United